SeekingAlpha · Apr 27, 2026
Ligand Pharmaceuticals Incorporated (LGND) XOMA Royalty Corporation - M&A Call - Slideshow
2026-04-27. The following slide deck was published by Ligand Pharmaceuticals Incorporated in conjunction with this event.
OTC · LGNDZ
Ligand Pharmaceuticals, Inc.
Healthcare · Medical - Pharmaceuticals
$0.00
Up+$0.00 (+0.00%)
Updated Nov 5, 2026, 9:17 PM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 157.46K
- P/E ratio
- 99
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.02
- Volume
- 300
- Avg. volume
- 56.76K
Price performance · LGNDZ
LGNDZ price history
1M range · 5 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
LGNDZ closed at $0.00 after 5 trading sessions, down 50.00% for the selected period.
- Last close
- $0.00
- Period change
- -50.00%
- Period low
- $0.00
- Period high
- $0.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $0.0017 | $0.0017 | $0.0017 | $0.0017 | 300 |
| Oct 28, 2026 | $0.0017 | $0.0017 | $0.0017 | $0.0017 | 12.6K |
| Oct 22, 2026 | $0.0026 | $0.0026 | $0.0026 | $0.0026 | 250 |
| Oct 20, 2026 | $0.0017 | $0.0017 | $0.0017 | $0.0017 | 650 |
| Oct 7, 2026 | $0.003 | $0.0034 | $0.003 | $0.0034 | 1K |
Latest LGNDZ news
The latest Smart Investors Daily articles mentioning LGNDZ.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LGNDZ research
Overview
Company profile and research snapshot.
Company profile
LIGAND PHARMS INC CVR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- —
- Implied upside
- —
- Analysts
- 13
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 30, 2026 | RBC Capital | Outperform | — |
| Sep 25, 2026 | Barclays | Overweight | — |
| Sep 24, 2026 | HC Wainwright & Co. | Buy | — |
| Sep 23, 2026 | Citigroup | Buy | — |
| Aug 14, 2026 | Leerink Partners | Outperform | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Apr 27, 2026
Ligand Pharmaceuticals Incorporated (LGND) M&A Call Transcript
Ligand Pharmaceuticals Incorporated (LGND) M&A Call April 27, 2026 8:00 AM EDTCompany ParticipantsMelanie HermanTodd Davis - CEO & DirectorOctavio...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
